The Board of Directors of Jounce Therapeutics (JNCE), a clinical-stage company focused on the discovery and development of novel cancer immunotherapies and predictive biomarkers, confirmed

Synchronoss Technologies (SNCR),  confirmed that on March 10, 2023, it received a non-binding proposal from B. Riley Financial to acquire all outstanding shares of the

Nano Dimension (NNDM), a leading supplier of Additively Manufactured Electronics and multi-dimensional polymer, metal & ceramic Additive Manufacturing 3D printers, announced that it has made

Neoleukin Therapeutics (NLTX), announced that it has engaged SVB Securities to assist in reviewing strategic alternatives for the company with the goal of maximizing shareholder

According to Reuters, Quotient Technology (QUOT), the parent of Coupons.com, is exploring options that include a sale of the company as it grapples with a

According to Reuters, OneSpan (OSPN), a U.S. cybersecurity tools vendor that has become the target of activist hedge funds such as Legion Partners Asset Management,

According to WSJ, Private-equity firm Apollo Global Management (APO) is in talks to acquire aerospace parts maker Arconic Corp. (ARNC). Apollo submitted a bid in

According to Reuters, Syneos Health Inc (SYNH), eyes sale of the company as contract backlog shrinks. Update(s): May 9, 2023: According to Bloomberg, A consortium that

Apexigen (APGN) a clinical-stage company focused on developing innovative antibody-based therapeutics for the treatment of cancer with a focus on immuno-oncology, announced that it has

According to WSJ, Pfizer (PFE) is in talks to acquire biotech Seagen (SGEN) in a deal likely valued at more than $30 billion. Previously on

Aileron Therapeutics (ALRN)  announced that it is exploring a range of strategic alternatives to maximize stockholder value. The company has engaged Ladenburg Thalmann & Co.,

Graphite Bio, Inc. (GRPH) announced that it has completed a review of its business, including the status of its programs, resources, and capabilities. In addition,